Researchers have found that exosomes in aggressive B-cell lymphomas and plasma cell-derived neoplasms convey oncogenic proteins (including MYC), immunomodulatory chemicals, and miRNAs that help blood vessels grow, make stroma more flexible, and help the cancer cells avoid the immune system [36]. This evidence concerns the gene MYC and cancer.